In the medical field, it often is desirable to separate low concentration cells from a fluid mixture with no harm to the cells, wash cells, concentrate cells in a fluid mixture, differentiate cells based on key parameters, or even fractionate many different types of cells. Such processes are key in the development of possible cures to many common diseases. It may also be desirable to separate particles or cells different in size, density and or acoustic contrast factor using an acoustic field where the particles may be separated from each other as well. Examples include the separation of live from dead cells and the separation of differentiated from undifferentiated cells. The methods described herein provide for such a separation or fractionation method that is label-free.
In the food and beverage industry, filter cartridges and filter membranes have conventionally been used to filter particles from liquids. Such filters are expensive and become clogged and non-functional as material is processed. In contrast, acoustophoresis provides, among other possible advantages, a solid-state, low-cost alternative to filter cartridges and filter membranes that is capable of processing large quantities of a host medium, for example water or beer, that is laden with yeast or other suspended particles.
In the food and beverage industry, host fluid is flowed through filters at flow rates up to ten times greater than those through conventional acoustophoresis devices. At these higher flow rates, trapping of the particles in the host fluid is decreased, thereby leading to decreased separation efficiency. It would therefore be desirable to provide systems and methods capable of separating a second fluid or a particulate from a host fluid at much higher flowrates, or at much lower concentrations, than conventional macro-scale acoustic separators.
In the oil and water industry, efficiently and economically separating oil and other contaminants from water has become an important process. The rise of fracking techniques has led to many settling ponds and large costs for transportation of contaminated water. These settling ponds are a challenge to the environment and better means are needed to clarify fracking water more effectively. Acoustophoresis provides, among other possible advantages, a solid-state, effective means of clarifying fracking, but the flow rates associated with such macro-scale acoustophoresis devices is still too low to be feasible. It would therefore be desirable to provide systems and methods capable of separating a second fluid, cell, or particulate from a host fluid at much higher flowrates.
This disclosure describes various embodiments of mini to macro-scale systems, devices, and methods for acoustophoresis to separate, fractionate, isolate, concentrate, wash, detect, or even differentiate cells or particles in fluid suspension. The devices and methods include a flow chamber and an ultrasonic transducer and reflector that set up an angled acoustic standing wave oriented at an acute angle relative to the direction of mean flow through the flow chamber, which includes the particle path through the angled acoustic standing wave. At higher flow rates, acoustic standing waves may be used to deflect the particles in a desired direction, without causing the particles to become trapped in the standing wave. By applying the acoustic standing wave to the host fluid at an angle thereto, desired deflection of the particles can be achieved.
These systems and methods can separate, sort, and differentiate various particles using bulk ultrasonic standing waves oriented at an angle γ relative to the fluid velocity. This approach offers a sensitive separation capability with respect to size and acoustic contrast of particles.
In one aspect, systems for separating material from a host fluid include: a flow chamber defining a direction of mean flow; an ultrasonic transducer including a piezoelectric material configured to be excited to generate an angled bulk acoustic standing wave with a wavelength and an acoustic radiation force in the flow chamber oriented at an acute angle relative to the direction of mean flow through the flow chamber, wherein the flow chamber has a minimum internal dimension that is at least 10 times the wavelength of the angled acoustic standing wave; a reflector opposite the at least one ultrasonic transducer; a first inlet fluidly connected to the flow chamber; a second inlet fluidly connected to the flow chamber; a first outlet fluidly connected to the flow chamber; and a second outlet fluidly connected to the flow chamber. Embodiments of these systems can include one or more of the following features.
In some embodiments, the first inlet is at least 0.1 inches (e.g., 0.2, 0.3, 0.4, 0.5, or 1 inch) from the angled bulk acoustic standing wave.
In some embodiments, systems also include a first channel ending at the first inlet, wherein the first channel has a substantially straight section extending at least 0.1 inches (e.g., 0.25, 0.5, 0.75, or 1 inch) from the first inlet.
In some embodiments, a space between the ultrasonic transducer and the reflector comprises a first portion within the flow chamber and a second portion outside the flow chamber. In some cases, systems also include an acoustically transparent material separating the first portion from the second portion. In some cases, systems also include a cooling water system in fluid connection with the second portion. In some cases, the second portion is filled with solid material having an acoustic impedance equal to an acoustic impedance of the host fluid.
In some embodiments, the system comprises a plurality of ultrasonic transducers.
In some embodiments, the first inlet and the second inlet are coaxial. In some cases, the first outlet and the second outlet are coaxial. In some cases, the first inlet has a rectangular cross-section. In some cases, an area of the rectangular cross-section of the first inlet is at least 0.05 square inches (e.g., 0.1, 0.25, 0.5, 0.75, or 1 inch).
In some embodiments, the first inlet has an aspect ratio of at least 5 (e.g., 10, 15, 20, 25, or 50).
In some embodiments, systems also include a third outlet, wherein second outlet is disposed between the first outlet and the third outlet and a cross-sectional area of the third outlet is smaller than a cross-sectional area of the second outlet. In some cases, the second outlet has a rectangular cross-section and third outlet has a rectangular cross-section. In some cases, a width of the second outlet is the same as a width of the third outlet. In some cases, a height of the second outlet is at least 2 times a height of the third outlet.
In some embodiments, systems also include a plurality of third outlets, each of the plurality of third outlets offset from an axis of the second outlet in a direction of deflection of the angled acoustic wave.
In some embodiments, systems also include a first channel ending at the first inlet, wherein the first channel has a substantially straight section extending at least 0.1 inches (e.g., 0.25, 0.5, 0.75, or 1 inch) from the first inlet at a first acute angle relative to a plane perpendicular to the angled acoustic standing wave. In some cases, a second channel ending at the second inlet, wherein the second channel has a substantially straight section extending at least 0.1 inches (e.g., 0.25, 0.5, 0.75, or 1 inch) from the second inlet at a second acute angle relative to the plane perpendicular to the angled acoustic standing wave. In some cases, the first acute and the second acute angle are equal. In some cases, system also include a third channel ending at the first outlet, wherein the third channel has a substantially straight section extending from the first outlet at a third acute angle relative to the plane perpendicular to the angled acoustic standing wave. In some cases, the first acute and the third acute angle are equal. In some cases, systems also include a fourth channel ending at the second outlet, wherein the first outlet located in a direction of deflection of the angled acoustic wave relative to the second outlet, wherein the fourth channel has a first cross-sectional area, the third channel has a first section with the first cross-sectional area and a second section with a second cross-sectional area that is smaller than the first cross-sectional area, and the second section of the third channel is located between the first outlet and the first section of the third channel. In some cases, the third channel has a substantially straight section extending from the first outlet at a third acute angle. In some cases, the first acute angle is between 80 degrees and 90 degrees.
In some embodiments, a wall of the flow chamber adjacent to the first outlet in a direction of deflection of the angled acoustic wave extends at an acute angle relative to a plane perpendicular to the angled acoustic standing wave. In some cases, the acute angle is between 1 and 20 degrees (e.g., more than 2 degrees, more than 3 degrees, more than 5 degrees, more than 10 degrees, less than 15 degrees, less than 10 degrees, less than 7.5 degrees, less than 5 degrees).
In one aspect, systems for separating material from a host fluid include: a flow chamber extending between a first end and a second end; an inlet located at the first end of the flow chamber; a first outlet located at between the first end of the flow chamber and the second end of the flow chamber, the inlet and the first outlet defining a direction of mean flow through the flow chamber; an ultrasonic transducer including a piezoelectric material configured to be excited to generate an angled acoustic standing wave between the inlet and the first outlet, the angled acoustic standing wave with a wavelength and an acoustic radiation force in the flow chamber oriented at an acute angle relative to the direction of mean flow through the flow chamber; and a reflector opposite the at least one ultrasonic transducer; wherein the first outlet is spaced apart from the second end of the flow chamber.
In some embodiments, the flow chamber has a minimum internal dimension that is at least 10 times the wavelength of the angled acoustic standing wave.
In some embodiments, the first outlet is located at least 0.5 inches from the second end of the flow chamber.
In some embodiments, the flow chamber has a distance between the first end and the second end and the first outlet is located at away from the second end by at least 30% of the distance. In some cases, the first outlet is located at away from the second end by at most 70% of the distance.
In some embodiments, systems also include a second outlet located at the second end of the chamber.
In one aspect, methods of separating material from a host fluid include: flowing an initial mixture of the host fluid and the material via an inlet into an acoustophoretic device at a flow rate, the acoustophoretic device including: an acoustic chamber communicating with the inlet; an ultrasonic transducer coupled to the chamber and arranged to be excited to produce an acoustic wave at an angle with a mean direction of flow of the initial mixture; controlling a ratio of acoustic radiation force produced by the ultrasonic transducer and a viscous drag force of the initial mixture to cause a first subgroup of the material passing through the acoustic wave to deflect at an angle that is different than that of a second subgroup of the material, to thereby permit the first and second subgroups to be separated. Embodiments of these methods can include one or more of the following features.
In some embodiments, methods also include controlling the ratio by controlling one or more of the angle, the flow rate, a frequency of excitation of the ultrasonic transducer or power supplied to the ultrasonic transducer.
In some embodiments, methods also include controlling the ratio based on characteristics of one or more subgroups. In some cases, methods also include controlling the ratio based on one or more of material size, density, compressibility or acoustic contrast factor.
In some embodiments, methods also include controlling the ratio to deflect at least some of the material at the angle of the acoustic wave.
In some embodiments, the material further includes a third subgroup that is different from the first subgroup and the second subgroup, and controlling the ratio further comprises causing the third subgroup to deflect at an angle that is different than that of the first subgroup or the second subgroup.
In some embodiments, methods also include controlling the ratio in a range that is determined by characteristics of subgroups of materials in the mixture to be separated. In some cases, the range is determined by the relative sizes of the material in the subgroups to be separated. In some cases, the range spans at least an order of magnitude.
In some embodiments, methods also include collecting the first subgroup or the second subgroup in a collection duct communicating with the acoustic chamber.
In some embodiments, the material comprises particulates, cells, or fluids, that include at least two subgroups possessing different characteristics.
These systems and methods can separate, sort, and differentiate various particles using bulk ultrasonic standing waves oriented at an angle γ relative to the fluid velocity. This approach offers a sensitive separation capability with respect to size and acoustic contrast of particles.
“Bulk acoustic standing waves” indicate acoustic waves that propagate through volume of a medium such as water with little attenuation. In contrast, “surface acoustic standing waves” are acoustic waves that travel along the surface of a material exhibiting elasticity, with an amplitude that typically decays exponentially with depth into the substrate. Surface acoustic waves do not penetrate very far into a volume of a medium such as water, e.g. several millimeters from a substrate into the water volume at most.
The singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise.
Numerical values should be understood to include numerical values which are the same when reduced to the same number of significant figures and numerical values which differ from the stated value by less than the experimental error of conventional measurement technique of the type described in the present application to determine the value.
All ranges disclosed herein are inclusive of the recited endpoint and independently combinable (for example, the range of “from 2 grams to 10 grams” is inclusive of the endpoints, 2 grams and 10 grams, and all the intermediate values). The endpoints of the ranges and any values disclosed herein are not limited to the precise range or value; they are sufficiently imprecise to include values approximating these ranges and/or values.
The modifier “about” used in connection with a quantity is inclusive of the stated value and has the meaning dictated by the context. When used in the context of a range, the modifier “about” should also be considered as disclosing the range defined by the absolute values of the two endpoints. For example, the range of “from about 2 to about 10” also discloses the range “from 2 to 10.” The term “about” may refer to plus or minus 10% of the indicated number. For example, “about 10%” may indicate a range of 9% to 11%, and “about 1” may mean from 0.9-1.1.
It should be noted that some of the terms used herein may be relative terms. For example, the terms “upper” and “lower” are relative to each other in location, i.e. an upper component is located at a higher elevation than a lower component in a given orientation, but these terms can change if the device is flipped. The terms “inlet” and “outlet” are relative to a fluid flowing through them with respect to a given structure, e.g. a fluid flows through the inlet into the structure and flows through the outlet out of the structure. The terms “upstream” and “downstream” are relative to the direction in which a fluid flows through various components, i.e. the flow fluids through an upstream component prior to flowing through the downstream component. It should be noted that in a loop, a first component can be described as being both upstream of and downstream of a second component.
The terms “horizontal” and “vertical” are used to indicate direction relative to an absolute reference, i.e. ground level. However, these terms should not be construed to require structures to be absolutely parallel or absolutely perpendicular to each other. For example, a first vertical structure and a second vertical structure are not necessarily parallel to each other. The terms “top” and “bottom” or “base” are used to refer to surfaces where the top is always higher than the bottom/base relative to an absolute reference, i.e. the surface of the earth. The terms “upwards” and “downwards” are also relative to an absolute reference; upwards is always against the gravity of the earth. It is to be understood that gravity, or the effects of gravity, are negligible in the angled wave deflection process described herein, because the process works on individual particles, not much larger particle clusters as used in other systems.
The term “parallel” should be construed in its lay sense of two surfaces that maintain a generally constant distance between them, and not in the strict mathematical sense that such surfaces will never intersect when extended to infinity.
Two numbers are of the same order of magnitude if the quotient of the larger number divided by the smaller number is a value of at least 1 and less than 10.
The details of one or more embodiments of these systems, devices, and methods are set forth in the accompanying drawings and the description below. Other features, objects, and advantages will be apparent from the description and drawings, and from the claims.
Like reference symbols in the various drawings indicate like elements.
The present disclosure relates to acoustophoretic devices that employ multi-dimensional ultrasonic acoustic standing waves, planar acoustic standing waves or combinations of planar and multidimensional acoustic standing waves (collectively referred to herein as angled acoustic standing waves) oriented at an angle relative to the direction of mean flow through the device. The direction of mean flow through the chamber is to be understood to include the path traveled by a second fluid, cell, or particulate that is flowed through an angled acoustic standing wave generated in the device. These angled acoustic standing waves deflect particles in a host fluid stream, rather than trapping the particles for agglomeration. This is an important distinction from many current acoustophoresis devices. These devices described can operate at high flowrates and can be used to replace costly and clog-prone filter cartridges and filter membranes in various industries. The devices and methods of the present disclosure rely primarily on the axial force component to deflect the particles out of the acoustic field, rather than relying on trapping, agglomeration, and gravitational and buoyancy forces. The devices and methods presented herein are capable of being operated independent of gravity (i.e., in any orientation), and do not rely on gravitational settling. In this way, the axial force of an angled acoustic standing wave oriented at an angle relative to the flow direction is capable of advantageously deflecting material (e.g., a second fluid, cells, beads or other particles, exosomes, viruses, oil droplets) in host fluid streams at high flow rates of up to about 400 mL/min, and more preferably up to about 600 mL/min or about 700 mL/min in devices with a cross section of 1 inch by 1 inch. Devices have also been produced with a 0.5 inch×0.5 inch total flow channel, with the center inlet being 0.1 inch×0.1 inch. For these devices, volumetric flow rates on the order of 0 to 100 ml/min with typical buffer flow rate of 20 to 100 ml/min and center flow rate of 1 to 10 ml/min. This corresponds to linear velocities on the order of 1 to 100 mm/sec regardless of the size of the device.
Thus, bulk acoustic standing waves angled relative to a direction of flow through a device can be used to deflect, collect, differentiate, or fractionate particles or cells from a fluid flowing through the device. The angled acoustic standing waves can be used to separate or fractionate particles in the fluid by size, density, speed of sound, or shape. The angled acoustic standing wave can be a three-dimensional acoustic standing wave. The acoustic standing wave may also be a planar wave where the piezoelectric material is excited in a piston fashion or the acoustic standing waves may be a combination of the planar acoustic standing waves and the multidimensional acoustic standing waves. For the purposes of this disclosure, a standing wave where the lateral force is at least an order of magnitude less than the magnitude of the axial force is considered a “planar acoustic standing wave.” However, standing waves that are not planar acoustic standing waves may be used with the approaches described in this disclosure as well. This can be used to separate live cells from dead cells, damaged cells from healthy cells, or differentiated from undifferentiated cells. The deflection of the particles by the standing wave can also be controlled or amplified by the strength of the acoustic field, the angle of the acoustic field, the properties of the fluid, the three dimensionality of the standing wave, the frequency of the standing wave, the acoustic chamber shape, and the mixture flow velocity.
When acoustic standing waves propagate in liquids, the fast oscillations may generate a non-oscillating force on particles suspended in the liquid or on an interface between liquids. This force is known as the acoustic radiation force. The force originates from the non-linearity of the propagating wave. As a result of the non-linearity, the wave is distorted as it propagates and the time-averages are nonzero. By serial expansion (according to perturbation theory), the first non-zero term will be the second-order term, which accounts for the acoustic radiation force. The acoustic radiation force on a particle, or a cell, in a fluid suspension is a function of the difference in radiation pressure on either side of the particle or cell. The physical description of the radiation force is a superposition of the incident wave and a scattered wave, in addition to the effect of the non-rigid particle oscillating with a different speed compared to the surrounding medium thereby radiating a wave. The following equation presents an analytical expression for the acoustic radiation force FR on a particle, or cell, in a fluid suspension in a standing wave.
where βm is the speed of sound in the fluid medium, ρ is density, X is acoustic contrast factor, VP is particle volume, λ is wavelength, k is 2π/λ, P0 is acoustic pressure amplitude, x is the axial distance along the standing wave (i.e., perpendicular to the wave front), and
where ρρ is the particle density, ρf is the fluid medium density, βρ is the compressibility of the particle, and βf is the compressibility of the fluid medium.
The acoustic radiation force on a particle is seen to be a symmetric function having a period that is one half the acoustic wavelength. This means the radiation force distribution repeats every half wavelength. This also means a particle will be accelerated and decelerated by the radiation force presented by Eq. (1).
An angled flow problem, as presented in
As such, ν is actually ΔVN, or the change in particle velocity normal to the standing wave resulting from the effects of the acoustic radiation forces on the particles as generated by the standing wave relative to the normal fluid flow velocity. The viscosity effects always oppose the perturbation velocity, and act in a direction toward the mean velocity. As a result, the viscosity always drives the particle perturbation velocity to fluctuate about the mean flow velocity with an amplitude of ΔVN. The particles in suspension are assumed small enough to instantly react to the viscous and radiation forces. With this assumption, the first term on the left side drops out, and Equation 3 can be reduced to:
v=C sin(2kx) (4)
where
C is the maximum perturbation velocity in the normal direction and is seen to be a function of the acoustic pressure amplitude, particle radius, acoustic contrast factor, fluid viscosity and the acoustic wavelength. With this assumption, the particle velocity instantly adjusts to the Stokes velocity generated by the radiation force.
The trajectory of the fluid compared to the average trajectory of a particle are also shown in
The problem of interest is to determine the particle deflection with acoustic wave angle under different flow and acoustic conditions. ΔVN is the maximum normal velocity perturbation, C, associated with a sinusoidal acoustic radiation force acting on a particle as shown in Eq. (4).
Particle or cell deflection can be characterized ΔV_N/V which is a non-dimensional parameter that will be defined as M in the following analytical equation development:
which can be expanded to
where C is the maximum normal velocity perturbation (ΔVN) from Eq. (4), and V is the fluid free stream velocity. This non-dimensional parameter, M, is important since it represents the ratio of acoustic radiation force on a particle, to the viscous drag force on the particle. M is the key parameter for particle deflection by an angled standing wave. Both acoustic pressure and particle size are squared in the expression. This means they are the most dominant factors for determining particle deflection. An accurate expression for particle deflection in an angled wave, in terms of M, can be obtained by solving particle movement with the normal wave, and then transforming the results to the angled wave flow field (i.e., using the Galilean transformation presented in
Equation 7 presents an expression for ΔtM which is the time it takes a particle in suspension to travel through one half wavelength of the normal standing wave (i.e. process repeats every half wavelength) as it is being accelerated and decelerated by the acoustic axial radiation force. Equation 8 is the expression for Δto which is the time it takes the fluid to pass through one half wavelength of the normal wave. These two time values are independent of the Galilean transformation, and combined with
The ratio of these times is defined as
Equations 10 and 11 use ε combined with the wave angle γ to generate an expression for particle deflection in the angled wave field.
An analytical solution for particle deflection as a function of wave angle and the non-dimensional parameter, M, defined by the ratio of acoustic radiation forces and viscous forces on a mixture flowing through an acoustic standing wave, was developed using substitution of variables. This analytical solution which allows particle deflection angle to be predicted for all values of M and γ, is shown in Eq. (12).
The triangular solution region under the 45° line shown in
Each M curve in
For example, the M=0.8 curve in the figure can represent many different applications. One exemplary application with M=0.8 has a fluid mixture velocity, V=7.75×10−4 m/sec, an acoustic standing wave wavelength, λ=7.4×10−4 m, a mixture viscosity, μ=1.0×10−3 Pa·s, a contrast factor, X=0.12, a mixture compressibility, βf=4.06×10−10 m2/N, particle radius, rp=3×10−6 m, and acoustic pressure amplitude, P0=1.0 MPa as a discussion point. The particle deflection curve presented in
The analytical model results, as presented in
Δθmax=sin−1(M)=γ (13)
Equation 13 defines the maximum deflection angle possible, and the wave angle γ needed for maximum particle deflection using angled acoustic standing waves as a function of the non-dimensional parameter M.
The M parameter can also be used to determine the desired operation characteristics, for example, to be used in deflecting extremely small particles in suspension. The smaller the particle size, the lower the M factor. Assuming flow velocity is reduced as low as possible for system feasibility, and power is increased as large as possible, then the M operating curves specify that the system should be operated at as low a wave angle as possible as particle deflection peaks at lower wave angles for low M values. This indicates that systems used with small particles, or nanoparticles, should be operated at extremely small angles (e.g., <5°, <4°, <3°, <2°, <1°).
The predictions presented above are based on analytical procedures for ideal standing waves and fluid velocity fields, and were used as guidance for more accurate numerical particle trajectory studies and experimental verification tests showing the benefits of using acoustic standing waves to deflect, collect, differentiate, separate, purify, or fractionate one population of particles or cells from a mixture that may contain multiple different types of particles, i.e., different in size and/or material properties such as density or compressibility.
The particle trajectory can be solved by numerically integrating the equation of motion of the particle, i.e., Eq. (3) given some initial conditions of the particle. The equation is solved by a fourth order Runge Kutta method with automatic time stepping. In the following results, a uniform velocity profile of fluid for a flow channel of one inch width is used. Typical conditions used in the computations are an acoustic standing wave with a frequency of 2 MHz and an acoustic pressure amplitude of 1 MPa. The acoustic standing wave has a width of one inch and has an angle of 45°.
The numerical particle trajectory model can easily be modified to take into account more realistic acoustic and flow fields. Computational Fluid Dynamics simulations can be done to determine the fluid velocities in a realistic fluid channel geometry. Similarly, numerical solvers for acoustic fields generated by piezoelectric transducers can be used to predict more accurate solutions for the acoustic field. The particle trajectory model can then make use of the numerically predicted acoustic and fluid velocity fields to obtain more realistic predictions. Another extension is the inclusion of gravitational and buoyancy forces acting on the particles.
Two macroscale, ultrasonic, angled wave separator configurations were fabricated and tested. Two different approaches were used to generate the desired fluid/acoustic interactions. The first concept is that of an Angled Wave Device (AWD) where an angled acoustic standing wave propagates through one or more parallel fluid streams flowing in a straight duct. The second is an Angled Fluid Device (AFD) where narrow fluid streams are injected and controlled to flow through an acoustic standing wave chamber at an angle to the standing wave. These macro scale, ultrasonic separators were shown to have the potential to operate effectively at much higher flow rates and/or at much lower particle concentrations, than conventional acoustic separators. For example, while earlier acoustic separators typically operate a linear velocity of less than 1 mm/s, the systems described in this disclosure can operate at linear velocities of up to 100 mm/s. The test results verified the analytical predictions, and demonstrated the potential to separate, or fractionate particles in suspension by size, density, and speed of sound using angled acoustic standing waves.
The AWD system 100 can be operated in horizontal and vertical orientations. Multiple inlets 110, 112 are shown on the right and multiple outlets 114, 116 on the left. The inlet 110 and the inlet 112 are coaxial rectangular ducts with an axis 107. In the orientation shown, the flow travels horizontally from right to left through a flow chamber 109, in this case a rectangular duct. In general, AWD systems include a piezoelectric material configured to be excited to generate an angled acoustic standing wave with a wavelength and an acoustic radiation force in the flow chamber oriented at an acute angle relative to the direction of mean flow through the flow chamber and the flow chamber has a minimum internal dimension that is at least 10 times (e.g., at least 50 times, at least 100 times, or at least 1000 times) the wavelength of the angled acoustic standing wave. In the AWD system 100, an angled standing wave is generated at 45° to the flow direction by a PZT-8, 1 MHz, 1 inch by 1 inch transducer and a stainless steel reflector. Optionally, some systems include multiple transducer/reflector pairs. The minimum internal dimension of the flow chamber 109 of this system is the height 108 of the flow chamber which is about 0.75 inches. In a test described in more detail below, the AWD system 100 was operated vertically with flow downwards to eliminate gravity effects on particle deflections. A mixture of polystyrene beads and water was pumped downward through the 0.2-inch middle inlet channel at a velocity of 155 cm/min. In the AWD system 100, the middle inlet channel (inlet 110) has a cross-sectional area of about 0.15 square inches. In general, AWD systems have mixture inlets with cross-sectional areas of between 0.01 and 2 square inches (e.g., 0.05, 0.1, 0.25, 0.5, 0.75, or 1 square inches).
The space between the ultrasonic transducer and the reflector has a first portion within the flow chamber and a second portion outside the flow chamber. In the acoustic chamber of the AWD system 100, thin acoustically transparent membranes 121 are used to separate the mixture flow from the prismatic void regions (i.e., the second portion outside the flow chamber) set up by the angular transducer and reflector set up. Optionally, the system can include cooling water system in fluid connection with the prismatic void regions. For example, pumps can circulate water through these regions to maintain a constant fluid temperature. In some systems, these prismatic void regions are filled with solid material having an acoustic impedance equivalent to the host fluid. This approach has been found to eliminate flow problems associated with the triangular regions while allowing the angled wave to pass with minimal reflections.
As shown in
The flow rates are set to generate laminar flow in the chamber and operate below a Reynolds number of 200 based on equivalent duct diameter. The low Reynolds number results in shear dominated flow, with no turbulence. The flow rate is set in three of the four streams. The two inlet flow rates are set to push the flow, and either outlet flow duct can be set to pull the flow. This push and pull operation assures the flow streams stay laminar and straight, and also provide a means to modify flow profiles for desired particle separation. The average buffer flow velocity can be set above or below the average flow velocity of the mixture flow. As the mixture flow passes through the angled, acoustic standing wave, the particles in suspension will be deflected downward along the wave front as shown. The particle deflection from the horizontal direction can vary from zero up to the wave direction. The deflection is a factor of the M factor. If the M factor is large enough to stop the flow through the waves, the particles will travel along the wave angle. The particles will be carried by the fluid velocity component parallel to the wave. The host fluid direction will be unaffected by the acoustics, and will travel horizontally to the mixture exit duct shown.
Typical velocity profiles through the acoustic section of the AWD system 100 are shown in
Buffer flow around the duct at the side edges as shown in
The M factor and particle deflection increases directly with electric power supplied to the transducer. The mixture stream was seen to deflect down at an angle less than the wave angle, as it moved through the angled wave from right to left for power up to 1.5 W (see
The bead diameter variation was calculated using the M factor based on power variation measured from first noticeable bead deflection to all bead deflection along the wave front. At a power of 1.5 W, the analytical calculations indicated that large particles of 200 μm were deflected along the wave front and a majority of all particles larger than 130 μm were deflected along the wave front at a power of 3.2 W. The analytical prediction is that identical values of the product of the square of particle diameter and acoustic energy, which is proportional to power, yield identical particle deflections. The results agree well with the documented size distribution for the beads and the observed bead behaviour. These test results verify the analytical model, and demonstrate the ability to select and differentiate by size or material property using angled wave technology.
Some AWD systems have a third outlet configured to concentrate material being deflected. For example, these systems can have the second outlet disposed between the first outlet and the third outlet where a cross-sectional area of the third outlet is smaller than a cross-sectional area of the second outlet.
Some AWD systems have a plurality of third outlets, each of the plurality of third outlets offset from an axis of the second outlet in a direction of deflection of the angled acoustic wave.
In one example, a mixed population of two particles of the same material, one of size 5 micron and one of size 10 micron need to be separated in a 45° angled wave device. Operating parameters such as flowrate, power, and frequency are selected such that the M-factor for the bigger particle is M10=0.8. For a 45° angled wave device, this M-factor that results in a particle deflection of 45 degree for the ten-micron particle. Since M scales with the square of the particle radius, the M-factor for the smaller particle is M5=0.8/4=0.2. The deflection angle for this particle is about two degrees. Therefore, a proper angled wave setup with a wave angle of 45° is able to fractionate these two populations.
In a second example, the goal is to fractionate three different cells, lymphocytes, monocytes, and neutrophils, cells found within the white blood cell population. Lymphocytes have a typical size of 6 micron. Monocytes and neutrophils are about ten microns. In addition, the acoustic contrast factor of the lymphocytes is smaller than that of the monocytes. A 45° degree angled wave device can be tuned such that the monocytes have an M-factor of 0.75. The neutrophils being of the same size and slightly smaller acoustic contrast factor have a slightly smaller M-factor of about 0.725. The smaller lymphocytes M-factor scales as ( 6/10)2=0.36, or 36% that of the monocytes, resulting in an M-factor of 0.27. The deflection curve for a 45° wave angle indicates that the monocytes and neutrophils deflect at 45°, whereas the lymphocytes deflect at about 5°. A system with properly designed outlets will be able to harvest separately the monocytes and neutrophils in one channel, and the lymphocytes in a separate outlet, thereby separating and enriching the lymphocytes.
In a third example, the goal is to fractionate the output of an affinity cell selection process. An 25 micron affinity bead is used for a TCR+ T-cell negative cell selection process. The TCR+ T-cells are bound to the affinity bead and form a complex of affinity bead with multiple TCR+ cells attached to the bead. The TCR− T-cells are not bound, remaining in solution as free unbound cells. An angled wave system is then used to fractionate these two populations, free unbound TCR− cells from the affinity bead/TCR+ cell complexes. The radius of the T-cell is about 6 micron. Therefore, the ratio of the M-factor is (25/6)2=17. Choosing system parameters such that the affinity/cell complex has an M-factor of 1 results in the deflection of the complex at the wave angle. The unbound free cell then has an M-factor of 1/17=0.06 which means the free cells deflect at an angle of less than 1°, thereby effectuating a fractionation process of the affinity bead/cell complex from the free cells.
In a fourth example, the goal is to fractionate a mixed cell populations consisting of similar sized cells but with a difference in acoustic contrast factor, with cell A having a contrast factor of 0.03 and cell B having a contrast factor of 0.06. An 45° angled wave system is used to separate cells A from cells B. The system is tuned such that the M-factor of cell B is 0.75, resulting in a deflection of cells B at an angle of 45°. Since the M-factor scales with the contrast factor, the M-factor for cell A is 0.75/2=0.375, resulting in a deflection of about 5 degrees for cell A. A properly designed system should allow for the separation of cells A at 5 degrees from cells B at 45 degrees.
The two lower exit ducts are at an angle beta (β) with the horizontal of 70°. In some systems, the angles alpha and beta are the same. In some systems, the four ducts all enter the acoustic chamber at different angles. These angles though, will vary between zero and ninety degrees. In some systems, the angle alpha is between 30° and 88° (e.g., more than 35°, more than 40°, more than 45°, more than 50°, more than 55°, more than 60°, less than 80°, less than 75°, less than 70°, less than 65°, less than 60°, less than 55°, less than 50°). In some systems, the angle beta is between 30° and 88° (e.g., more than 35°, more than 40°, more than 45°, more than 50°, more than 55°, more than 60°, less than 80°, less than 75°, less than 70°, less than 65°, less than 60°, less than 55°, less than 50°).
Fluid enters the acoustic chamber through the inlet ducts, and exits the chamber through the exit ducts. Typical duct dimensions are channels depths of 0.5 to 1 inch and channel widths of 0.1 to 0.4 inches. The flow rates are set to generate laminar flow in the chamber and operate below a Reynolds number of 200 based on duct diameter. The low Reynolds number results in shear dominated flow, with no turbulence. The flow rate is set in three of the four ducts attached to the acoustic chamber in
In
Some systems are configured to provide fractionation by providing a constriction in the outlet channel positioned to receive deflected material. For example, the fourth channel ending at the second outlet can have a first cross-sectional area. The third channel ending at the first outlet can have a first section with the first cross-sectional area and a second section with a second cross-sectional area that is smaller than the first cross-sectional area with the second section of the third channel located between the first outlet and the first section of the third channel.
The systems and methods described in this disclosure can provide macro-scale, ultrasonic separators that use bulk, acoustic standing waves angled to the direction of a fluid mixture flow field to generate particle deflection that can be used to collect, differentiate, separate, purify, or fractionate one population of particles or cells from a mixture that may contain multiple different types of particles. Particle trajectory equations provide the key physics. The universal prediction curves developed for particle deflection at all wave angles as a function of the non-dimensional parameter M defined by the ratio of acoustic radiation force to viscous drag force on the particle can be used in system design and operation. Particle deflection, measured from the fluid flow direction, varies continuously from zero to a maximum value equal to the wave angle γ, which is the angle that the standing wave makes with the flow direction. The analytical results agreed well with both numerical trajectory computations and model test results. The acoustic pressure amplitude, particle diameter and wave angle were shown to have the largest effect on particle deflection.
Results also showed that for any acoustic pressure amplitude of a standing wave, there is a wave angle of the standing wave where the radiation force stops the particle velocity normal to the wave, and as a result, the particles start to move along the wave front. This point is defined by the non-dimensional parameter M, and angle of the wave γ and operating near this point generates large particle deflection with small changes in controllable parameters such as acoustic power or flow velocity. This operating point is quite useful, since it could allow the separation of particles with minute size, stiffness or density differences.
Some of these systems and methods use standing waves angled to a flow channel or narrow flow streams injected at an angle through a fixed acoustic chamber. Both systems were shown to effectively separate polystyrene beads from a flowing mixture at high speeds when compared to conventional ultrasonic separators. Such macro scale, ultrasonic separators were also shown to effectively operate at much higher flow rates, or at much lower particle concentrations, than conventional acoustic separators. Model test results agreed very well with theory, and verified the prediction system developed. The angled wave system could work with a fluid/substance mixture where the substance in suspension could be micro carrier beads, cells, exosomes, virus, oil, or any material that has a different density, compressibility, or contrast factor than the host fluid. The analytical model predicts that the system can theoretically work even with nanoparticles since the acoustic radiation force effect is amplified by the angle the flow makes with the acoustic wave.
A number of embodiments of the invention have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of the invention.
For example,
In another example,
In another example,
Accordingly, other embodiments are within the scope of the following claims.
This application is a continuation-in-part application of Ser. No. 15/613,790 which is a divisional application of Ser. No. 15/143,481 which claims priority to U.S. Provisional Patent Application Ser. No. 62/316,933, filed on Apr. 1, 2016; and to U.S. Provisional Patent Application Ser. No. 62/154,690, filed on Apr. 29, 2015. This application also claims priority to U.S. Provisional Patent Application Ser. No. 62/479,309, filed on Mar. 30, 2017; and to U.S. Provisional Patent Application Ser. No. 62/485,229, filed on Apr. 13, 2017. All of these applications are incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
2473971 | Ross | Jun 1949 | A |
2667944 | Crites | Feb 1954 | A |
3372370 | Cyr | Mar 1968 | A |
3555311 | Weber | Jan 1971 | A |
4055491 | Porath-Furedi | Oct 1977 | A |
4065875 | Srna | Jan 1978 | A |
4118649 | Schwartzman et al. | Oct 1978 | A |
4125789 | Van Schoiack | Nov 1978 | A |
4158629 | Sawyer | Jun 1979 | A |
4165273 | Azarov et al. | Aug 1979 | A |
4173725 | Asai et al. | Nov 1979 | A |
4204096 | Barcus et al. | May 1980 | A |
4254661 | Kossoff et al. | Mar 1981 | A |
4320659 | Lynnworth et al. | Mar 1982 | A |
4344448 | Potts | Aug 1982 | A |
4398325 | Piaget et al. | Aug 1983 | A |
4484907 | Sheeran, Jr. | Nov 1984 | A |
4552669 | Sekellick | Nov 1985 | A |
4666595 | Graham | May 1987 | A |
4673512 | Schram | Jun 1987 | A |
4699588 | Zinn et al. | Oct 1987 | A |
4743361 | Schram | May 1988 | A |
4759775 | Peterson et al. | Jul 1988 | A |
4800316 | Wang | Jan 1989 | A |
4821838 | Chen | Apr 1989 | A |
4836684 | Javorik et al. | Jun 1989 | A |
4860993 | Goode | Aug 1989 | A |
4878210 | Mitome | Oct 1989 | A |
4983189 | Peterson et al. | Jan 1991 | A |
5059811 | King et al. | Oct 1991 | A |
5062965 | Bernou et al. | Nov 1991 | A |
5085783 | Feke et al. | Feb 1992 | A |
5164094 | Stuckart | Nov 1992 | A |
5225089 | Benes et al. | Jul 1993 | A |
5371429 | Manna | Dec 1994 | A |
5395592 | Bolleman et al. | Mar 1995 | A |
5431817 | Braatz et al. | Jul 1995 | A |
5443985 | Lu et al. | Aug 1995 | A |
5452267 | Spevak | Sep 1995 | A |
5475486 | Paoli | Dec 1995 | A |
5484537 | Whitworth | Jan 1996 | A |
5527460 | Trampler et al. | Jun 1996 | A |
5560362 | Sliwa, Jr. et al. | Oct 1996 | A |
5562823 | Reeves | Oct 1996 | A |
5594165 | Madanshetty | Jan 1997 | A |
5604301 | Mountford et al. | Feb 1997 | A |
5626767 | Trampler et al. | May 1997 | A |
5688405 | Dickinson et al. | Nov 1997 | A |
5711888 | Trampler et al. | Jan 1998 | A |
5831166 | Kozuka et al. | Nov 1998 | A |
5834871 | Puskas | Nov 1998 | A |
5902489 | Yasuda et al. | May 1999 | A |
5912182 | Coakley et al. | Jun 1999 | A |
5947299 | Vazquez et al. | Sep 1999 | A |
5951456 | Scott | Sep 1999 | A |
6090295 | Raghavarao et al. | Jun 2000 | A |
6166231 | Hoeksema | Dec 2000 | A |
6216538 | Yasuda et al. | Apr 2001 | B1 |
6205848 | Faber et al. | Jun 2001 | B1 |
6273262 | Yasuda et al. | Aug 2001 | B1 |
6332541 | Coakley et al. | Dec 2001 | B1 |
6391653 | Letcher et al. | May 2002 | B1 |
6475151 | Koger et al. | Nov 2002 | B2 |
6482327 | Mori et al. | Nov 2002 | B1 |
6487095 | Malik et al. | Nov 2002 | B1 |
6592821 | Wada et al. | Jul 2003 | B1 |
6641708 | Becker et al. | Nov 2003 | B1 |
6649069 | DeAngelis | Nov 2003 | B2 |
6699711 | Hahn et al. | Mar 2004 | B1 |
6727451 | Fuhr et al. | Apr 2004 | B1 |
6763722 | Fjield et al. | Jul 2004 | B2 |
6881314 | Wang et al. | Apr 2005 | B1 |
6929750 | Laurell et al. | Aug 2005 | B2 |
6936151 | Lock et al. | Aug 2005 | B1 |
7008540 | Weavers et al. | Mar 2006 | B1 |
7010979 | Scott | Mar 2006 | B2 |
7061163 | Nagahara et al. | Jun 2006 | B2 |
7081192 | Wang et al. | Jul 2006 | B1 |
7093482 | Berndt | Aug 2006 | B2 |
7108137 | Lal et al. | Sep 2006 | B2 |
7150779 | Meegan, Jr. | Dec 2006 | B2 |
7186502 | Vesey | Mar 2007 | B2 |
7191787 | Redeker et al. | Mar 2007 | B1 |
7322431 | Ratcliff | Jan 2008 | B2 |
7331233 | Scott | Feb 2008 | B2 |
7340957 | Kaduchak et al. | Mar 2008 | B2 |
7373805 | Hawkes et al. | May 2008 | B2 |
7541166 | Belgrader et al. | Jun 2009 | B2 |
7601267 | Haake et al. | Oct 2009 | B2 |
7673516 | Janssen et al. | Mar 2010 | B2 |
7674630 | Siversson | Mar 2010 | B2 |
7837040 | Ward et al. | Nov 2010 | B2 |
7846382 | Strand et al. | Dec 2010 | B2 |
7968049 | Takahashi et al. | Jun 2011 | B2 |
8075786 | Bagajewicz | Dec 2011 | B2 |
8080202 | Takahashi et al. | Dec 2011 | B2 |
8134705 | Kaduchak et al. | Mar 2012 | B2 |
8256076 | Feller | Sep 2012 | B1 |
8266950 | Kaduchak et al. | Sep 2012 | B2 |
8273253 | Curran | Sep 2012 | B2 |
8273302 | Takahashi et al. | Sep 2012 | B2 |
8309408 | Ward et al. | Nov 2012 | B2 |
8319398 | Vivek et al. | Nov 2012 | B2 |
8334133 | Fedorov et al. | Dec 2012 | B2 |
8387803 | Thorslund et al. | Mar 2013 | B2 |
8592204 | Lipkens et al. | Nov 2013 | B2 |
8679338 | Rietman et al. | Mar 2014 | B2 |
8691145 | Dionne et al. | Apr 2014 | B2 |
8873051 | Kaduchak et al. | Oct 2014 | B2 |
8889388 | Wang et al. | Nov 2014 | B2 |
9272234 | Lipkens et al. | Mar 2016 | B2 |
9357293 | Claussen | May 2016 | B2 |
9365815 | Miyazaki et al. | Jun 2016 | B2 |
9368110 | Hershey et al. | Jun 2016 | B1 |
9388363 | Goodson et al. | Jul 2016 | B2 |
9391542 | Wischnewskiy | Jul 2016 | B2 |
9403114 | Kusuura | Aug 2016 | B2 |
9410256 | Dionne et al. | Aug 2016 | B2 |
9416344 | Lipkens et al. | Aug 2016 | B2 |
9421553 | Dionne et al. | Aug 2016 | B2 |
9422328 | Kennedy, III et al. | Aug 2016 | B2 |
9457139 | Ward et al. | Oct 2016 | B2 |
9457302 | Lipkens et al. | Oct 2016 | B2 |
9458450 | Lipkens et al. | Oct 2016 | B2 |
9464303 | Burke | Oct 2016 | B2 |
9476855 | Ward et al. | Oct 2016 | B2 |
9480375 | Marshall et al. | Nov 2016 | B2 |
9480935 | Mariella, Jr. et al. | Nov 2016 | B2 |
9488621 | Kaduchak et al. | Nov 2016 | B2 |
9504780 | Spain et al. | Nov 2016 | B2 |
9512395 | Lipkens et al. | Dec 2016 | B2 |
9513205 | Yu et al. | Dec 2016 | B2 |
9514924 | Morris et al. | Dec 2016 | B2 |
9517474 | Mao et al. | Dec 2016 | B2 |
9532769 | Dayton et al. | Jan 2017 | B2 |
9533241 | Presz, Jr. et al. | Jan 2017 | B2 |
9550134 | Lipkens et al. | Jan 2017 | B2 |
9550998 | Williams | Jan 2017 | B2 |
9556271 | Blumberg et al. | Jan 2017 | B2 |
9556411 | Lipkens et al. | Jan 2017 | B2 |
9566352 | Holmes et al. | Feb 2017 | B2 |
9567559 | Lipkens et al. | Feb 2017 | B2 |
9567609 | Paschon et al. | Feb 2017 | B2 |
9572897 | Bancel et al. | Feb 2017 | B2 |
9573995 | Schurpf et al. | Feb 2017 | B2 |
9574014 | Williams et al. | Feb 2017 | B2 |
9580500 | Schurpf et al. | Feb 2017 | B2 |
9587003 | Bancel et al. | Mar 2017 | B2 |
9597357 | Gregory et al. | Mar 2017 | B2 |
9597380 | Chakraborty et al. | Mar 2017 | B2 |
9605074 | Shah | Mar 2017 | B2 |
9605266 | Rossi et al. | Mar 2017 | B2 |
9606086 | Ding et al. | Mar 2017 | B2 |
9608547 | Ding et al. | Mar 2017 | B2 |
9611465 | Handa et al. | Apr 2017 | B2 |
9616090 | Conway et al. | Apr 2017 | B2 |
9623348 | McCarthy et al. | Apr 2017 | B2 |
9629877 | Cooper et al. | Apr 2017 | B2 |
D787630 | Lipkens et al. | May 2017 | S |
9644180 | Kahvejian et al. | May 2017 | B2 |
9645060 | Fiering | May 2017 | B2 |
9656263 | Laurell et al. | May 2017 | B2 |
9657290 | Dimov et al. | May 2017 | B2 |
9662375 | Jensen et al. | May 2017 | B2 |
9663756 | Lipkens et al. | May 2017 | B1 |
9670477 | Lipkens et al. | Jun 2017 | B2 |
9670938 | Beliavsky | Jun 2017 | B2 |
9675668 | Bancel et al. | Jun 2017 | B2 |
9675902 | Lipkens et al. | Jun 2017 | B2 |
9675906 | Lipkens et al. | Jun 2017 | B2 |
9677055 | Jones et al. | Jun 2017 | B2 |
9685155 | Hershey et al. | Jun 2017 | B2 |
9686096 | Lipkens et al. | Jun 2017 | B2 |
9688958 | Kennedy, III et al. | Jun 2017 | B2 |
9689234 | Gregory et al. | Jun 2017 | B2 |
9689802 | Caseres et al. | Jun 2017 | B2 |
9695063 | Rietman et al. | Jul 2017 | B2 |
9695442 | Guschin et al. | Jul 2017 | B2 |
9810665 | Fernald et al. | Nov 2017 | B2 |
9833763 | Fernald et al. | Dec 2017 | B2 |
9869659 | Buckland et al. | Jan 2018 | B2 |
9872900 | Ciaramella et al. | Jan 2018 | B2 |
9873126 | Mao et al. | Jan 2018 | B2 |
9873894 | Conway et al. | Jan 2018 | B2 |
9878056 | Bancel et al. | Jan 2018 | B2 |
9878536 | Foresti et al. | Jan 2018 | B2 |
9879087 | DeSander et al. | Jan 2018 | B2 |
9990297 | Conway et al. | Jan 2018 | B2 |
9907846 | Morein et al. | Mar 2018 | B2 |
9908288 | Harkness | Mar 2018 | B2 |
9909117 | Kaduchak | Mar 2018 | B2 |
9909313 | Grubbs | Mar 2018 | B1 |
9913656 | Stulen | Mar 2018 | B2 |
9913866 | O'Shea et al. | Mar 2018 | B2 |
9925277 | Almarsson et al. | Mar 2018 | B2 |
9926382 | Fischer et al. | Mar 2018 | B2 |
9937207 | Gregory et al. | Apr 2018 | B2 |
9938390 | Storti et al. | Apr 2018 | B2 |
9943599 | Gehl et al. | Apr 2018 | B2 |
9944702 | Galetto | Apr 2018 | B2 |
9944709 | Galetto | Apr 2018 | B2 |
9994743 | El-Zahab | Apr 2018 | B2 |
9974898 | Spain et al. | May 2018 | B2 |
20020038662 | Schuler et al. | Apr 2002 | A1 |
20020134734 | Campbell et al. | Sep 2002 | A1 |
20030015035 | Kaduchak et al. | Jan 2003 | A1 |
20030028108 | Miller et al. | Feb 2003 | A1 |
20030195496 | Maguire | Oct 2003 | A1 |
20030209500 | Kock et al. | Nov 2003 | A1 |
20030230535 | Affeld et al. | Dec 2003 | A1 |
20040016699 | Bayevsky | Jan 2004 | A1 |
20040035208 | Diaz et al. | Feb 2004 | A1 |
20040057866 | Zumeris et al. | Mar 2004 | A1 |
20040112841 | Scott | Jun 2004 | A1 |
20040124155 | Meegan, Jr. | Jul 2004 | A1 |
20040149039 | Cardelius | Aug 2004 | A1 |
20050031499 | Meier | Feb 2005 | A1 |
20050121269 | Namduri | Jun 2005 | A1 |
20050145567 | Quintel et al. | Jul 2005 | A1 |
20050196725 | Fu | Sep 2005 | A1 |
20050239198 | Kunas | Oct 2005 | A1 |
20060037915 | Strand et al. | Feb 2006 | A1 |
20060037916 | Trampler | Feb 2006 | A1 |
20060050615 | Swisher | Mar 2006 | A1 |
20070053795 | Laugharn, Jr. et al. | Mar 2007 | A1 |
20070138108 | Hadfield et al. | Jun 2007 | A1 |
20070224676 | Haq | Sep 2007 | A1 |
20070267351 | Roach et al. | Nov 2007 | A1 |
20070272618 | Gou et al. | Nov 2007 | A1 |
20070284299 | Xu et al. | Dec 2007 | A1 |
20080011693 | Li et al. | Jan 2008 | A1 |
20080067128 | Hoyos et al. | Mar 2008 | A1 |
20080105625 | Rosenberg et al. | May 2008 | A1 |
20080181838 | Kluck | Jul 2008 | A1 |
20080217259 | Siversson | Sep 2008 | A1 |
20080245709 | Kaduchak et al. | Oct 2008 | A1 |
20080245745 | Ward et al. | Oct 2008 | A1 |
20080264716 | Kuiper et al. | Oct 2008 | A1 |
20080272034 | Ferren et al. | Nov 2008 | A1 |
20080272065 | Johnson | Nov 2008 | A1 |
20080316866 | Goodemote et al. | Dec 2008 | A1 |
20090029870 | Ward et al. | Jan 2009 | A1 |
20090042253 | Hiller et al. | Feb 2009 | A1 |
20090048805 | Kaduchak et al. | Feb 2009 | A1 |
20090053686 | Ward et al. | Feb 2009 | A1 |
20090087492 | Johnson et al. | Apr 2009 | A1 |
20090098027 | Tabata et al. | Apr 2009 | A1 |
20090104594 | Webb | Apr 2009 | A1 |
20090126481 | Burris | May 2009 | A1 |
20090178716 | Kaduchak et al. | Jul 2009 | A1 |
20090194420 | Mariella, Jr. et al. | Aug 2009 | A1 |
20090227042 | Gauer et al. | Sep 2009 | A1 |
20090045107 | Ward et al. | Dec 2009 | A1 |
20090295505 | Mohammadi et al. | Dec 2009 | A1 |
20100000945 | Gavalas | Jan 2010 | A1 |
20100078323 | Takahashi et al. | Apr 2010 | A1 |
20100078384 | Yang | Apr 2010 | A1 |
20100124142 | Laugharn et al. | May 2010 | A1 |
20100139377 | Huang et al. | Jun 2010 | A1 |
20100192693 | Mudge et al. | Aug 2010 | A1 |
20100193407 | Steinberg et al. | Aug 2010 | A1 |
20100206818 | Leong et al. | Aug 2010 | A1 |
20100255573 | Bond et al. | Oct 2010 | A1 |
20100261918 | Chianelli et al. | Oct 2010 | A1 |
20100317088 | Radaelli et al. | Dec 2010 | A1 |
20100323342 | Gonzalez Gomez et al. | Dec 2010 | A1 |
20100330633 | Walther et al. | Dec 2010 | A1 |
20110003350 | Schafran et al. | Jan 2011 | A1 |
20110024335 | Ward et al. | Feb 2011 | A1 |
20110092726 | Clarke | Apr 2011 | A1 |
20110095225 | Eckelberry et al. | Apr 2011 | A1 |
20110123392 | Dionne et al. | May 2011 | A1 |
20110125024 | Mueller | May 2011 | A1 |
20110146678 | Ruecroft et al. | Jun 2011 | A1 |
20110154890 | Holm et al. | Jun 2011 | A1 |
20110166551 | Schafer | Jul 2011 | A1 |
20110189732 | Weinand et al. | Aug 2011 | A1 |
20110207225 | Mehta et al. | Aug 2011 | A1 |
20110245750 | Lynch et al. | Oct 2011 | A1 |
20110262990 | Wang et al. | Oct 2011 | A1 |
20110278218 | Dionne et al. | Nov 2011 | A1 |
20110281319 | Swayze et al. | Nov 2011 | A1 |
20110309020 | Rietman et al. | Dec 2011 | A1 |
20120088295 | Yasuda et al. | Apr 2012 | A1 |
20120145633 | Polizzotti et al. | Jun 2012 | A1 |
20120161903 | Thomas et al. | Jun 2012 | A1 |
20120163126 | Campbell et al. | Jun 2012 | A1 |
20120175012 | Goodwin et al. | Jul 2012 | A1 |
20120231504 | Niazi | Sep 2012 | A1 |
20120267288 | Chen et al. | Oct 2012 | A1 |
20120325727 | Dionne et al. | Dec 2012 | A1 |
20120325747 | Reitman et al. | Dec 2012 | A1 |
20120328477 | Dionne et al. | Dec 2012 | A1 |
20120329122 | Lipkens et al. | Dec 2012 | A1 |
20130017577 | Arunakumari et al. | Jan 2013 | A1 |
20130115664 | Khanna et al. | May 2013 | A1 |
20130175226 | Coussios et al. | Jul 2013 | A1 |
20130206688 | El-Naas | Aug 2013 | A1 |
20130217113 | Srinivasan et al. | Aug 2013 | A1 |
20130277316 | Dutra et al. | Oct 2013 | A1 |
20130277317 | LoRicco et al. | Oct 2013 | A1 |
20130284271 | Lipkens et al. | Oct 2013 | A1 |
20130316412 | Schultz et al. | Nov 2013 | A1 |
20140011240 | Lipkens et al. | Jan 2014 | A1 |
20140017758 | Kniep et al. | Jan 2014 | A1 |
20140102947 | Baym et al. | Apr 2014 | A1 |
20140141413 | Laugham, Jr. et al. | May 2014 | A1 |
20140154795 | Lipkens et al. | Jun 2014 | A1 |
20140319077 | Lipkens et al. | Oct 2014 | A1 |
20140329997 | Kennedy, III et al. | Nov 2014 | A1 |
20140377834 | Presz, Jr. et al. | Dec 2014 | A1 |
20150053561 | Ward et al. | Feb 2015 | A1 |
20150060581 | Santos et al. | Mar 2015 | A1 |
20150252317 | Lipkens et al. | Sep 2015 | A1 |
20150274550 | Lipkens et al. | Oct 2015 | A1 |
20150321129 | Lipkens et al. | Nov 2015 | A1 |
20160060615 | Walther et al. | Mar 2016 | A1 |
20160089620 | Lipkens et al. | Mar 2016 | A1 |
20160102284 | Lipkens et al. | Apr 2016 | A1 |
20160121331 | Kapur et al. | May 2016 | A1 |
20160123858 | Kapur et al. | May 2016 | A1 |
20160145563 | Berteau et al. | May 2016 | A1 |
20160153249 | Mitri | Jun 2016 | A1 |
20160175198 | Warner et al. | Jun 2016 | A1 |
20160184790 | Sinha et al. | Jun 2016 | A1 |
20160202237 | Zeng et al. | Jul 2016 | A1 |
20160208213 | Doyle et al. | Jul 2016 | A1 |
20160230168 | Kaduchak et al. | Aug 2016 | A1 |
20160237110 | Gilmanshin et al. | Aug 2016 | A1 |
20160237394 | Lipkens et al. | Aug 2016 | A1 |
20160237395 | Lipkens et al. | Aug 2016 | A1 |
20160252445 | Yu et al. | Sep 2016 | A1 |
20160279540 | Presz, Jr. et al. | Sep 2016 | A1 |
20160279551 | Foucault | Sep 2016 | A1 |
20160287778 | Leach | Oct 2016 | A1 |
20160312168 | Pizzi | Oct 2016 | A1 |
20160314868 | El-Zahab et al. | Oct 2016 | A1 |
20160319270 | Lipkens et al. | Nov 2016 | A1 |
20160325039 | Leach et al. | Nov 2016 | A1 |
20160325206 | Presz, Jr. et al. | Nov 2016 | A1 |
20160332159 | Dual et al. | Nov 2016 | A1 |
20160339360 | Lipkens et al. | Nov 2016 | A1 |
20160347628 | Dionne et al. | Dec 2016 | A1 |
20160355776 | Lipkens et al. | Dec 2016 | A1 |
20160361670 | Lipkens et al. | Dec 2016 | A1 |
20160363579 | Lipkens et al. | Dec 2016 | A1 |
20160368000 | Dionne et al. | Dec 2016 | A1 |
20160369236 | Kennedy, III et al. | Dec 2016 | A1 |
20160370326 | Kaduchak et al. | Dec 2016 | A9 |
20170000413 | Clymer et al. | Jan 2017 | A1 |
20170002060 | Bolen et al. | Jan 2017 | A1 |
20170002839 | Burkland et al. | Jan 2017 | A1 |
20170007679 | Maeder et al. | Jan 2017 | A1 |
20170008029 | Lipkens et al. | Jan 2017 | A1 |
20170016025 | Poirot et al. | Jan 2017 | A1 |
20170016027 | Lee et al. | Jan 2017 | A1 |
20170020926 | Mata-Fink et al. | Jan 2017 | A1 |
20170029802 | Lipkens et al. | Feb 2017 | A1 |
20170035866 | Poirot et al. | Feb 2017 | A1 |
20170037386 | Jones et al. | Feb 2017 | A1 |
20170038288 | Ward et al. | Feb 2017 | A1 |
20170042770 | Warner et al. | Feb 2017 | A1 |
20170044517 | Lipkens et al. | Feb 2017 | A1 |
20170049949 | Gilmanshin et al. | Feb 2017 | A1 |
20170056448 | Glick et al. | Mar 2017 | A1 |
20170058036 | Ruiz-Opazo et al. | Mar 2017 | A1 |
20170065636 | Moriarty et al. | Mar 2017 | A1 |
20170066015 | Lipkens et al. | Mar 2017 | A1 |
20170067021 | Moriarty et al. | Mar 2017 | A1 |
20170067022 | Poirot et al. | Mar 2017 | A1 |
20170072405 | Mao et al. | Mar 2017 | A1 |
20170073406 | Schurpf et al. | Mar 2017 | A1 |
20170073423 | Juillerat et al. | Mar 2017 | A1 |
20170073638 | Campana et al. | Mar 2017 | A1 |
20170073684 | Rossi et al. | Mar 2017 | A1 |
20170073685 | Maeder et al. | Mar 2017 | A1 |
20170080070 | Weinschenk et al. | Mar 2017 | A1 |
20170080423 | Dauson et al. | Mar 2017 | A1 |
20170081629 | Lipkens et al. | Mar 2017 | A1 |
20170088809 | Lipkens et al. | Mar 2017 | A1 |
20170088844 | Williams | Mar 2017 | A1 |
20170089826 | Lin | Mar 2017 | A1 |
20170096455 | Baric et al. | Apr 2017 | A1 |
20170107536 | Zhang et al. | Apr 2017 | A1 |
20170107539 | Yu et al. | Apr 2017 | A1 |
20170119820 | Moriarty et al. | May 2017 | A1 |
20170128523 | Ghatnekar et al. | May 2017 | A1 |
20170128857 | Lipkens et al. | May 2017 | A1 |
20170130200 | Moriarty et al. | May 2017 | A1 |
20170136168 | Spain et al. | May 2017 | A1 |
20170137491 | Matheson et al. | May 2017 | A1 |
20170137774 | Lipkens et al. | May 2017 | A1 |
20170137775 | Lipkens et al. | May 2017 | A1 |
20170137802 | Lipkens et al. | May 2017 | A1 |
20170145094 | Galetto | May 2017 | A1 |
20170151345 | Shah | Jun 2017 | A1 |
20170152502 | Scharenberg et al. | Jun 2017 | A1 |
20170152503 | Scharenberg et al. | Jun 2017 | A1 |
20170152504 | Scharenberg et al. | Jun 2017 | A1 |
20170152505 | Scharenberg et al. | Jun 2017 | A1 |
20170152527 | Paschon et al. | Jun 2017 | A1 |
20170152528 | Zhang et al. | Jun 2017 | A1 |
20170158749 | Cooper et al. | Jun 2017 | A1 |
20170159005 | Lipkens et al. | Jun 2017 | A1 |
20170159007 | Lipkens et al. | Jun 2017 | A1 |
20170166860 | Presz, Jr. et al. | Jun 2017 | A1 |
20170166877 | Bayle et al. | Jun 2017 | A1 |
20170166878 | Thanos et al. | Jun 2017 | A9 |
20170166903 | Zhang et al. | Jun 2017 | A1 |
20170173080 | Lee et al. | Jun 2017 | A1 |
20170173128 | Hoge et al. | Jun 2017 | A1 |
20170173498 | Lipkens et al. | Jun 2017 | A9 |
20170175073 | Lipkens et al. | Jun 2017 | A1 |
20170175125 | Welstead et al. | Jun 2017 | A1 |
20170175139 | Wu et al. | Jun 2017 | A1 |
20170175144 | Zhang et al. | Jun 2017 | A1 |
20170175509 | Abdel-Fattah et al. | Jun 2017 | A1 |
20170175720 | Tang et al. | Jun 2017 | A1 |
20170183390 | Springer et al. | Jun 2017 | A1 |
20170183413 | Galetto | Jun 2017 | A1 |
20170183418 | Galetto | Jun 2017 | A1 |
20170183420 | Gregory et al. | Jun 2017 | A1 |
20170184486 | Mach et al. | Jun 2017 | A1 |
20170189450 | Conway et al. | Jul 2017 | A1 |
20170190767 | Schurpf et al. | Jul 2017 | A1 |
20170191022 | Lipkens et al. | Jul 2017 | A1 |
20170232439 | Suresh et al. | Aug 2017 | A1 |
20170374730 | Flores | Dec 2017 | A1 |
20180000311 | Lipkens et al. | Jan 2018 | A1 |
20180000870 | Britt | Jan 2018 | A1 |
20180000910 | Chakraborty et al. | Jan 2018 | A1 |
20180008707 | Bussmer et al. | Jan 2018 | A1 |
20180009158 | Harkness et al. | Jan 2018 | A1 |
20180009888 | Baumeister et al. | Jan 2018 | A9 |
20180009895 | Smith et al. | Jan 2018 | A1 |
20180010085 | Lipkens et al. | Jan 2018 | A1 |
20180010117 | Paschon et al. | Jan 2018 | A1 |
20180014846 | Rhee | Jan 2018 | A1 |
20180015128 | Britt | Jan 2018 | A1 |
20180015392 | Lipkens et al. | Jan 2018 | A1 |
20180016570 | Lipkens et al. | Jan 2018 | A1 |
20180016572 | Tang | Jan 2018 | A1 |
20180020295 | Pander et al. | Jan 2018 | A1 |
20180021379 | Galetto et al. | Jan 2018 | A1 |
20180022798 | Shurpf et al. | Jan 2018 | A1 |
20180028683 | Wong et al. | Feb 2018 | A1 |
20180043473 | Helvajian et al. | Feb 2018 | A1 |
20180049767 | Gee et al. | Feb 2018 | A1 |
20180051089 | Galettto et al. | Feb 2018 | A1 |
20180051265 | Cooper | Feb 2018 | A1 |
20180052095 | Cumbo et al. | Feb 2018 | A1 |
20180052147 | Zeng | Feb 2018 | A1 |
20180055529 | Messerly et al. | Mar 2018 | A1 |
20180055530 | Messerly et al. | Mar 2018 | A1 |
20180055531 | Messerly et al. | Mar 2018 | A1 |
20180055532 | Messerly et al. | Mar 2018 | A1 |
20180055997 | Cabrera et al. | Mar 2018 | A1 |
20180056095 | Messerly et al. | Mar 2018 | A1 |
20180057810 | Zhang et al. | Mar 2018 | A1 |
20180058439 | Locke et al. | Mar 2018 | A1 |
20180066223 | Lim | Mar 2018 | A1 |
20180066224 | Lipkens et al. | Mar 2018 | A1 |
20180066242 | Zhang | Mar 2018 | A1 |
20180067044 | Kaduchak et al. | Mar 2018 | A1 |
20180071363 | Ghatnekar et al. | Mar 2018 | A1 |
20180071981 | Collino et al. | Mar 2018 | A1 |
20180078268 | Messerly | Mar 2018 | A1 |
20180080026 | Rossi et al. | Mar 2018 | A1 |
20180085743 | Yavorsky et al. | Mar 2018 | A1 |
20180087044 | Lipkens et al. | Mar 2018 | A1 |
20180088083 | Sinha | Mar 2018 | A1 |
20180092338 | Hering et al. | Apr 2018 | A1 |
20180092660 | Houser et al. | Apr 2018 | A1 |
20180094022 | Bracewell et al. | Apr 2018 | A1 |
20180095067 | Huff et al. | Apr 2018 | A1 |
20180098785 | Price et al. | Apr 2018 | A1 |
20180100134 | Lim | Apr 2018 | A1 |
20180100204 | O'Shea | Apr 2018 | A1 |
20180130491 | Mathur | May 2018 | A1 |
Number | Date | Country |
---|---|---|
2002236405 | Sep 2002 | AU |
105 087 788 | Nov 2015 | CN |
104722106 | Apr 2016 | CN |
30 27 433 | Feb 1982 | DE |
32 18 488 | Nov 1983 | DE |
196 48 519 | Jun 1998 | DE |
103 19 467 | Jul 2004 | DE |
10 2008 006 501 | Sep 2008 | DE |
10 2014 206 823 | Oct 2015 | DE |
0 292 470 | Nov 1988 | EP |
0 167 406 | Jul 1991 | EP |
0 641 606 | Mar 1995 | EP |
1 175 931 | Jan 2002 | EP |
1 254 669 | Nov 2002 | EP |
1 308 724 | May 2003 | EP |
2 209 545 | Jul 2010 | EP |
270152 | Jan 2018 | EP |
2419511 | Jan 2018 | EP |
3068888 | Jan 2018 | EP |
3257600 | Jan 2018 | EP |
3274453 | Jan 2018 | EP |
3274454 | Jan 2018 | EP |
3275894 | Jan 2018 | EP |
278108 | Feb 2018 | EP |
3279315 | Feb 2018 | EP |
3286214 | Feb 2018 | EP |
2289535 | Mar 2018 | EP |
2545068 | Mar 2018 | EP |
2675540 | Mar 2018 | EP |
2750683 | Mar 2018 | EP |
2796102 | Mar 2018 | EP |
3066201 | Mar 2018 | EP |
3066998 | Mar 2018 | EP |
3107552 | Mar 2018 | EP |
3288660 | Mar 2018 | EP |
3288683 | Mar 2018 | EP |
3289362 | Mar 2018 | EP |
3291842 | Mar 2018 | EP |
3291852 | Mar 2018 | EP |
3292142 | Mar 2018 | EP |
3292195 | Mar 2018 | EP |
3292515 | Mar 2018 | EP |
3294343 | Mar 2018 | EP |
3294764 | Mar 2018 | EP |
3294857 | Mar 2018 | EP |
3294871 | Mar 2018 | EP |
3294888 | Mar 2018 | EP |
3294896 | Mar 2018 | EP |
3296302 | Mar 2018 | EP |
3297740 | Mar 2018 | EP |
3298046 | Mar 2018 | EP |
3164488 | Apr 2018 | EP |
3301115 | Apr 2018 | EP |
3302783 | Apr 2018 | EP |
3302789 | Apr 2018 | EP |
3303558 | Apr 2018 | EP |
3306310 | Apr 2018 | EP |
2 420 510 | May 2006 | GB |
9-136090 | May 1997 | JP |
1442486 | Sep 2014 | KR |
2037327 | Jun 1995 | RU |
2085933 | Jul 1997 | RU |
629496 | Oct 1978 | SU |
WO 198707178 | Dec 1987 | WO |
WO 8911899 | Dec 1989 | WO |
WO 9005008 | Mar 1990 | WO |
WO 9501214 | Jan 1995 | WO |
WO 9734643 | Sep 1997 | WO |
WO 1998017373 | Apr 1998 | WO |
WO 9850133 | Nov 1998 | WO |
WO 0041794 | Jul 2000 | WO |
WO 02072234 | Sep 2002 | WO |
WO 02072236 | Sep 2002 | WO |
WO 03089567 | Oct 2003 | WO |
WO 2004079716 | Sep 2004 | WO |
WO 2009063198 | May 2009 | WO |
WO 2009111276 | Sep 2009 | WO |
WO 2009144709 | Dec 2009 | WO |
WO 2010024753 | Apr 2010 | WO |
WO 2010040394 | Apr 2010 | WO |
WO 2011023949 | Mar 2011 | WO |
WO 2011025890 | Mar 2011 | WO |
WO 2011027146 | Mar 2011 | WO |
WO 2011131947 | Oct 2011 | WO |
WO 2011161463 | Dec 2011 | WO |
WO 2013043044 | Mar 2013 | WO |
WO 2013043297 | Mar 2013 | WO |
WO 2013049623 | Apr 2013 | WO |
WO 2013055517 | Apr 2013 | WO |
WO 2013138797 | Sep 2013 | WO |
WO 2013148376 | Oct 2013 | WO |
WO 2013159014 | Oct 2013 | WO |
WO 2014014941 | Jan 2014 | WO |
WO 2014029505 | Feb 2014 | WO |
WO 2014046605 | Mar 2014 | WO |
WO 2014055219 | Apr 2014 | WO |
WO 2014124306 | Aug 2014 | WO |
WO 2014153651 | Oct 2014 | WO |
WO 2015006730 | Jan 2015 | WO |
WO 2015102528 | Jul 2015 | WO |
WO 2016004398 | Jan 2016 | WO |
WO 2016124542 | Aug 2016 | WO |
WO 2016176663 | Nov 2016 | WO |
WO 2016209082 | Dec 2016 | WO |
WO 2017041102 | Mar 2017 | WO |
WO 20174201349 | Nov 2017 | WO |
WO 2017218714 | Dec 2017 | WO |
WO 2018009894 | Jan 2018 | WO |
WO 2018002036 | Jan 2018 | WO |
WO 2018005873 | Jan 2018 | WO |
WO 2018013558 | Jan 2018 | WO |
WO 2018013629 | Jan 2018 | WO |
WO 2018013840 | Jan 2018 | WO |
WO2018014174 | Jan 2018 | WO |
WO2018015561 | Jan 2018 | WO |
WO 20180011600 | Jan 2018 | WO |
WO2018018958 | Feb 2018 | WO |
WO2018021920 | Feb 2018 | WO |
WO2018022158 | Feb 2018 | WO |
WO2018022513 | Feb 2018 | WO |
WO2018022619 | Feb 2018 | WO |
WO2018022651 | Feb 2018 | WO |
WO2018022930 | Feb 2018 | WO |
WO2018023114 | Feb 2018 | WO |
WO2018024639 | Feb 2018 | WO |
WO2018026644 | Feb 2018 | WO |
WO2018026941 | Feb 2018 | WO |
WO2018028647 | Feb 2018 | WO |
WO 2018034343 | Feb 2018 | WO |
WO2018034885 | Feb 2018 | WO |
WO 2018035141 | Feb 2018 | WO |
WO 2018035423 | Feb 2018 | WO |
WO20180202691 | Feb 2018 | WO |
WO2018034655 | Mar 2018 | WO |
WO 2018038711 | Mar 2018 | WO |
WO 2018039119 | Mar 2018 | WO |
WO 2018039407 | Mar 2018 | WO |
WO 2018039408 | Mar 2018 | WO |
WO 2018039410 | Mar 2018 | WO |
WO 2018039412 | Mar 2018 | WO |
WO 2018039515 | Mar 2018 | WO |
WO 2018045284 | Mar 2018 | WO |
WO 2018049226 | Mar 2018 | WO |
WO 2018050738 | Mar 2018 | WO |
WO 2018057825 | Mar 2018 | WO |
WO 2018063291 | Apr 2018 | WO |
WO 2018081476 | May 2018 | WO |
WO 20180814701 | May 2018 | WO |
Entry |
---|
Ding et al., Cell separation using tilted-angle standing surface acoustic waves, Sep. 9, 2014, PNAS, vol. 111, No. 36, pp. 12992-12997 (Year: 2014). |
Rogers et al., Exploitation of surface acoustic waves to drive size-dependent microparticle concentration within a drop, 2010, Lab Chip, 10, 2979-2985, (Year: 2010). |
Barnkob et al., Acoustic radiation- and streaming-inducted microparticle velocities determined by microparticle image velocimetry in an ultrasound symmetry plane), 2012, Physical Review E, 86, pp. 056307-1 to 056307-11 (Year: 2012). |
Alvarez et al.; Shock Waves, vol. 17, No. 6, pp. 441-447, 2008. |
Augustsson et al., Acoustophoretic microfluidic chip for sequential elution of surface bound molecules from beads or cells, Biomicrofluidics, Sep. 2012, 6(3):34115. |
Benes et al.; Ultrasonic Separation of Suspended Particles, 2001 IEEE Ultrasonics Symposium; Oct. 7-10, 2001; pp. 649-659; Atlanta, Georgia. |
Castilho et al.; Animal Cell Technology: From Biopharmaceuticals to Gene Therapy; 11—Animal Cell Separation; 2008. |
Castro; Tunable gap and quantum quench dynamics in bilayer graphene; Jul. 13, 2010; Mathematica Summer School. |
Chitale et al.; Understanding the Fluid Dynamics Associated with Macro Scale Ultrasonic Separators; Proceedings of Meetings on Acoustics, May 2015. |
Cravotto et al.; Ultrasonics Sonochemistry, vol. 15, No. 5, pp. 898-902, 2008. |
Garcia-Lopez, et al; Enhanced Acoustic Separation of Oil-Water Emulsion in Resonant Cavities. The Open Acoustics Journal. 2008, vol. 1, pp. 66-71. |
Grenvall et al.; Concurrent Isolation of Lymphocytes and Granulocytes Using Prefocused Free Flow Acoustophoresis; Analytical Chemistry; vol. 87; pp. 5596-5604; 2015. |
Higginson et al.; Tunable optics derived from nonlinear acoustic effects; Journal of Applied Physics; vol. 95; No. 10; pp. 5896-5904; 2004. |
Hill et al.; Ultrasonic Particle Manipulation; Microfluidic Technologies for Miniaturized Analysis Systems, Jan. 2007, pp. 359-378. |
Ilinskii et al.; Acoustic Radiation Force on a Sphere in Tissue; AIP Conference Proceedings; 2012. |
Kuznetsova et al.; Microparticle concentration in short path length ultrasonic resonators: Roles of radiation pressure and acoustic streaming; Journal of the Acoustical Society of America, American Institute of Physics for the Acoustical Society of America, vol. 116, No. 4, Oct. 1, 2004, pp. 1956-1966, DOI: 1.1121/1.1785831. |
Latt et al.; Ultrasound-membrane hybrid processes for enhancement of filtration properties; Ultrasonics sonochemistry 13.4 (2006): 321-328. |
Li et al.; Electromechanical behavior of PZT-brass unimorphs; J. Am. Ceram. Soc. vol. 82; No. 7; pp. 1733-1740, 1999. |
Lipkens et al.; The effect of frequency sweeping and fluid flow on particle trajectories in ultrasonic standing waves; IEEE Sensors Journal, vol. 8, No. 6, pp. 667-677, 2008. |
Lipkens et al.; Frequency sweeping and fluid flow effects on particle trajectories in ultrasonic standing waves; Acoustics 08, Paris, Jun. 29-Jul. 4, 2008. |
Lipkens et al.; Prediction and measurement of particle velocities in ultrasonic standing waves; J. Acoust. Soc. Am., 124 No. 4, pp. 2492 (A) 2008. |
Lipkens et al.; Separation of micron-sized particles in macro-scale cavities by ultrasonic standing waves; Presented at the International Congress on Ultrasonics, Santiago; Jan. 11-17, 2009. |
Lipkens et al.; Separation of bacterial spores from flowering water in macro-scale cavities by ultrasonic standing waves; submitted/uploaded to http://arxiv.org/abs/1006.5467 on Jun. 28, 2010. |
Lipkens et al., Macro-scale acoustophoretic separation of lipid particles from red blood cells, The Journal of the Acoustical Society of America, vol. 133, Jun. 2, 2013, p. 045017, XP055162509, New York, NY. |
Meribout et al.; An Industrial-Prototype Acoustic Array for Real-Time Emulsion Layer Detection in Oil Storage Tanks; IEEE Sensors Journal, vol. 9, No. 12, Dec. 2009. |
Musiak et al.; Design of a Control System for Acoustophoretic Separation, 2013 IEEE 56th International Midwest Symposium on Circuits and Systems (MWSCAS), Aug. 2013, pp. 1120-1123. |
Nilsson et al.; Review of cell and particle trapping in microfluidic systems; Department of Measurement Technology and Industrial Electrical Engineering, Div. of Nanobiotechnology, Lund University, P.O. Box 118. Lund, Sweden, Analytica Chimica Acta 649, Jul. 14, 2009, pp. 141-157. |
Pangu et al.; Droplet transport and coalescence kinetics in emulsions subjected to acoustic fields; Ultrasonics 46, pp. 289-302 (2007). |
Phys. Org. “Engineers develop revolutionary nanotech water desalination membrane.” Nov. 6, 2006. http://phys.org/news82047372.html. |
Ponomarenko et al.; Density of states and zero Landau level probed through capacitance of graphene; Nature Nanotechnology Letters, Jul. 5, 2009; DOI: 10.1038/NNANO.2009.177. |
“Proceedings of the Acoustics 2012 Nantes Conference,” Apr. 23-27, 2012, Nantes, France, pp. 278-282. |
Ryll et al.; Performance of Small-Scale CHO Perfusion Cultures Using an Acoustic Cell Filtration Device for Cell Retention: Characterization of Separation Efficiency and Impact of Perfusion on Product Quality; Biotechnology and Bioengineering; vol. 69; Iss. 4; pp. 440-449; Aug. 2000. |
Seymour et al, J. Chem. Edu., 1990, 67(9), p. 763, published Sep. 1990. |
Volpin et al.; Mesh simplification with smooth surface reconstruction; Computer Aided Design; vol. 30; No. 11; 1998. |
Wang et al.; Retention and Viability Characteristics of Mammalian Cells in an Acoustically Driven Polymer Mesh; Biotechnol. Prog. 2004, pp. 384-387 (2004). |
Wicklund et al.; Ultrasonic Manipulation of Single Cells; Methods in Molecular Biology; vol. 853; pp. 1777-196; 2012. |
Annex to Form PCT/ISA/206—Communication Relating to the Results of the Partial International Search Report dated Jul. 18, 2013. |
European Search Report of European Application No. 11769474.5 dated Sep. 5, 2013. |
European Search Report of European Application No. 11796470.0 dated Jan. 5, 2016. |
European Search Report of European Application No. 13760840.2, dated Feb. 4, 2016. |
European Search Report of European Application No. 13721179.3 dated Mar. 23, 2016. |
European Search Report for European Application No. 14749278.9 dated Jan. 13, 2017. |
Extended European Search Report for European Application No. EP 12833859.7 dated Mar. 20, 2015. |
Extended European Search Report for European Application No. EP 14787587.6 dated Jan. 2, 2017. |
International Search Report and Written Opinion for International Application No. PCT/US2011/032181 dated Dec. 20, 2011. |
International Search Report and Written Opinion for International Application No. PCT/US2011/040787 dated Feb. 27, 2012. |
International Search Report and Written Opinion for International Application No. PCT/US2012/051804 dated Nov. 16, 2012. |
International Search Report and Written Opinion for International Application No. PCT/US2013/037404 dated Jun. 21, 2013. |
International Search Report and Written Opinion for International Application No. PCT/US2013/032705 dated Jul. 26, 2013. |
International Search Report and Written Opinion for International Application No. PCT/US2013/050729 dated Sep. 25, 2013. |
International Search Report and Written Opinion for International Application No. PCT/US2013/059640 dated Feb. 18, 2014. |
International Search Report and Written Opinion for International Application No. PCT/US2014/015382 dated May 6, 2014. |
International Search Report and Written Opinion for International Application No. PCT/US2014/035557 dated Aug. 27, 2014. |
International Search Report and Written Opinion for International Application No. PCT/US2014/043930 dated Oct. 22, 2014. |
International Search Report and Written Opinion for International Application No. PCT/US2014/046412 dated Oct. 27, 2014. |
International Search Report and Written Opinion for International Application No. PCT/US2014/064088 dated Jan. 30, 2015. |
International Search Report and Written Opinion for International Application No. PCT/US2015/010595 dated Apr. 15, 2015. |
International Search Report and Written Opinion for International Application No. PCT/US2015/019755 dated May 4, 2015. |
International Search Report and Written Opinion for International Application No. PCT/US2015/030009 dated Jul. 30, 2015. |
International Search Report and Written Opinion for International Application No. PCT/US2015/039125 dated Sep. 30, 2015. |
International Search Report and Written Opinion for International Application No. PCT/US2015/053200 dated Dec. 28, 2015. |
International Search Report and Written Opinion for International Application No. PCT/US2015/066884, dated Mar. 22, 2016. |
International Search Report and Written Opinion for International Application No. PCT/US2016/024082 dated Jun. 27, 2016. |
International Search Report and Written Opinion for International Application No. PCT/US2016/031357 dated Jul. 26, 2016. |
International Search Report and Written Opinion for International Application No. PCT/US2016/038233 dated Sep. 26, 2016. |
International Search Report and Written Opinion for International Application No. PCT/US2015/024365 dated Oct. 13, 2016. |
International Search Report and Written Opinion for International Application No. PCT/US2016/041664 dated Oct. 18, 2016. |
International Search Report and Written Opinion for International Application No. PCT/US2016/044586 dated Oct. 21, 2016. |
International Search Report and Written Opinion for International Application No. PCT/US2016/049088 dated Nov. 28, 2016. |
International Search Report and Written Opinion for International Application No. PCT/US2016/050415 dated Nov. 28, 2016. |
International Search Report and Written Opinion for International Application No. PCT/US2016/037104 dated Dec. 16, 2016. |
International Search Report and Written Opinion for International Application No. PCT/US2017/015197 dated Apr. 3, 2017. |
International Search Report and Written Opinion for International Application No. PCT/US2017/015450 dated Apr. 10, 2017. |
International Search Report and Written Opinion for International Application No. PCT/US2016/047217 dated Apr. 11, 2017. |
International Search Report and Written Opinion for International Application No. PCT/US2016/048243 dated Apr. 20, 2017. |
International Search Report and Written Opinion for International Application No. PCT/US2017/017788 dated May 8, 2017. |
International Search Report and Written Opinion for International Application No. PCT/US2017/030903 dated Jul. 19, 2017. |
International Search Report and Written Opinion for International Application No. PCT/US2017/025108 dated Jul. 20, 2017. |
International Search Report and Written Opinion for International Application No. PCT/US2017/031425 dated Aug. 30, 2017. |
Sony New Release: <http://www.sony.net/SonyInfo/News/Press/201010/10-137E/index.html>. |
International Search Report and Written Opinion for International Application No. PCT/US2017/031425 dated Oct. 23, 2017. |
Number | Date | Country | |
---|---|---|---|
20180298371 A1 | Oct 2018 | US |
Number | Date | Country | |
---|---|---|---|
62316933 | Apr 2016 | US | |
62154690 | Apr 2015 | US | |
62479309 | Mar 2017 | US | |
62485229 | Apr 2017 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15143481 | Apr 2016 | US |
Child | 15613790 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15613790 | Jun 2017 | US |
Child | 15942316 | US |